Aims/hypothesis. Lipids and lipoproteins, particularly triglyceride rich lipoproteins, could influence the development and progression of microalbuminuria in diabetes. Lipoprotein lipase gene variants have been found to correlate with lipid/lipoprotein concentrations, especially hypertriglyceridaemia. We assessed the influence of this gene on microalbuminuria in Type II (insulin-dependent) diabetes mellitus. Methods. Microalbuminuria was determined quantitatively in 386 sequential Type II diabetic patients by measurement of the albumin-to-creatinine ratio (ACR). DNA was analysed for two common intronic LPL single nucleotide polymorphisms (Pvu II, intron 6, and Hind III, intron 8), and three common exonic mutations (Asp 9 -Asn, exon 2, Asn 291 -Ser, exon 6, and Ser 447 -Ter, exon 9). Results. Individuals with P 2 P 2 (Pvu II) and H 2 H 2 (Hind III) genotypes had significantly greater ACRs (P 2 P 2 vs P 1 P 1 +P 1 P 2 , 5.0±0.5 vs 3.4±0.3, p=0.0004 and H 2 H 2 vs H 1 H 1 +H 1 H 2 , 4.3±0.4 vs 3.4±0.3, p=0.04). Logistic regression analysis demonstrated that only the P 2 P 2 genotype (p=0.0004), systolic BP (p=0.008) and creatinine (p=0.031) were independently associated with the presence of microalbuminuria/proteinuria. P 2 homozygotes were 170% more likely to have microalbuminuria or proteinuria, O.R. 2.7 (1.6-4.5, p=0.0001), 150% more likely to have microalbuminuria, O.R. 2.5 (1.5-4.3, p=0.001), and 330% more likely to have proteinuria, O.R. 4.3 (1.6-11.4, p=0.004). There were no associations of microalbuminuria with any of the exonic polymorphisms. Conclusion/interpretation. Genetic variants of lipoprotein lipase correlate with presence and severity of microalbuminuria in Type II diabetes, independent of effect on serum lipids. This association is only apparent in genetic variants demonstrating greatest heterozygosity. [Diabetologia (2002) 45:905-913] 
some authors question the specificity of proteinuria for DN in Type II diabetes, and the dose-response relationship between glycaemia and DN has not been shown in Type II diabetes. The similarities between Type I and Type II diabetes justify examination of the cause of DN in both diseases.
Consideration of hereditary factors predisposing certain individuals to DN is supported by familial studies in a number of ethnic populations [11, 12, 13] . A role for lipids in the development and progression of renal failure [14] was subsequently supported by animal experimental models of renal insufficiency [15] , and observational studies in diabetic and non-diabetic humans [16, 17, 18, 19, 20, 21] . This relationship could be more pronounced with triglyceride-rich lipoproteins which contain apo-B100, such as VLDL and IDL [22] .
Lipoprotein lipase (LPL), a hydrolytic enzyme bound to the vascular endothelium, is a rate limiting enzyme for the clearance of triglyceride-rich lipoproteins from the circulation, from both exogenous (chylomicrons) and endogenous (VLDL) sources [23] . We and others have previously found that genetic variants of LPL relate to dyslipidaemia and atherosclerosis, including concentrations of triglycerides [24, 25, 26, 27, 28, 29] , high density lipoprotein cholesterol (HDL-C) [24, 25, 30, 31, 32] , and total cholesterol [25, 29, 31] , development [24, 25, 33] and severity [24, 26] of coronary artery disease, familial combined hyperlipidaemia [34, 35] and familial chylomicronaemia [36] . Recently, no relationship was found between an exonic LPL polymorphism and Type I diabetic nephropathy [37] , although a potent effect of total cholesterol, triglycerides and apo-B was noted on DN.
We therefore investigated whether the LPL gene influences microalbuminuria in Type II diabetic patients.
Subjects and methods
Patients. Altogether 386 men and women with Type II diabetes consecutively attending the diabetes clinic were specifically recruited for our study to undergo detailed clinical characterisation and genetic analysis. A clinical diagnosis of Type II diabetes was made according to World Health Organisation (WHO) criteria, and all such consenting patients were enrolled, only excluding those with other renal pathologies which could influence microalbuminuria. Hypertension was defined as a sitting office blood pressure of more than 140/90 on two occasions or use of anti-hypertensive medication; hypercholesterolaemia was defined as total cholesterol >5.0 mmol/l or use of lipid lowering medication; current smoking was defined as any regular use of tobacco products during the previous month.
Although the pre-diagnosis duration of Type II diabetes is often not clear, and the diagnosis could only be discovered due to symptomatology or opportunistic screening, it would appear appropriate to utilise the earliest assessment of MA after diagnosis, before the confounding effects of treatment for hypertension/lipids or duration of follow-up. We therefore correlated the earliest available demographic and clinical (including MA) data following diagnosis with genotypic data, see Table 1 . MA had been determined quantitatively, with the patient clinically DNA analysis. DNA was isolated from frozen EDTA whole blood and genotyped for single nucleotide polymorphisms in intron 6 (Pvu II) and intron 8 (Hind III) as described elsewhere [24] . This yields P 2 and H 2 alleles in the presence of restriction sites. Coding sequence polymorphisms in exon 2 (Asp 9 -Asn), 6 (Asn 291 -Ser) and 9 (Ser 447 -Ter) were genotyped as previously described [24, 32, 38] , yielding alleles G and A, R 1 and R 2 , and C and G respectively in the presence and absence of the restriction sites (Table 2) .
Statistical analysis. Statistical analyses were done using the SPSS version 7.5 for Windows and S-Plus (MathSoft Inc) statistical packages. Discrete variables were analysed with Fisher's exact test. Continuous variables were analysed with Student's t test for variables with a normal distribution, and MannWhitney U test or Kruskal-Wallis test for those with a nonparametric distribution. Multiple regression analyses were done to ascertain which factors were predictive of microalbuminuria, independent of potential confounding variables. Binary logistic regression analysis was performed utilising normoalbuminuria versus MA/proteinuria, by an enter model. Linear regression was performed utilising microalbuminuria as a continuous variable by an enter model. Covariates analysed were age, systolic BP, diastolic BP, duration of diabetes, HbA 1 , total cholesterol, HDL-C, triglycerides and serum creatinine, entered as continuous variables. Binary variables included smoking, gender and genotype. Patients homozygous for the P 2 allele were compared with all individuals possessing the P 1 allele. Substitution for missing data was performed on continuous variables using the mean of available values, and for discrete variables we simulated data from a uniform distribution and assigned a value of 0 or 1 to the missing data, depending on whether the actual proportion in the variable is less or greater than a random number (as advised by Statistical Consultancy Unit, Department of Statistics, University of Warwick). Power calculations demonstrated that using the standard deviation of ACR measurements in our institute, a cohort of 267 would be required to detect a 30% difference with 80% power at the 5% significance level, and a cohort of 385 to detect a 25% difference. As there was no published data examining the effect of the LPL gene on microalbuminuria in Type II diabetes on which to base these analyses, these calculations predicted a nominal effect size, which could be observed with any of the genetic polymorphisms investigated.
Results
Patient demographics (Table 1) reveal that Caucasians were significantly older, showed a trend toward more frequent smoking, had higher BMI, total cholesterol and HDL-C. Females were older, less likely to be current smokers, had higher total cholesterol and HDL-C, lower diastolic BP and creatinine. Females were also less likely to have proteinuria, but had higher ACRs, excluding proteinurics. ACR measurements were available in 317 patients. 19 .7% of the cohort had a serum creatinine above the reference range for our institute. The non-Caucasian group was ethnically heterogenous, being made up of Indian-Asians (n=43, 11.1%), South-East Asians (n=40, 10.4%), African/Afro-Caribbeans (n=30, 7.8%) and others (n=7, 1.8%). There were no differences in any of these demographic factors by genotype (data not shown).
The genotype and allele frequencies were in HardyWeinberg equilibrium in the whole cohort and ethnic sub-groups which also includes the calculated heterozygosity indices (Table 2) . Despite repeated attempts, 15 (3.9%) samples could not be analysed for Hind III, 18 (4.7%) for Pvu II, 25 (6.5%) for Asp 9 -Asn, 17 (4.4%) for Asn 291 -Ser and 15 (3.9%) for Ser 447 -Ter. The Hind III and Pvu II polymorphisms were in linkage disequilibrium (p<0.0001), and both were in linkage disequilibrium with the exon 9 coding sequence mutation (p<0.0001). Of the exonic mutations, the A allele (Asp 9 -Asn) was observed in 4% of the population, the R 2 allele (Asn 291 -Ser) in only 1% of the whole cohort and 2% of Caucasians, and the G allele (Ser 447 -Ter) in 10% of the full cohort and 11% of Caucasians. We found no associations between any of these exonic alleles and microalbuminuria (data not shown).
A small number of patients (n=20) had ACRs in the proteinuric range, and although arbitrary thresholds define this group from microalbuminuria, analysis was done both including and excluding these patients to evaluate their influence upon our observations. Examination of these ACR values by Pvu II and Hind III genotypes within the whole cohort, and Caucasians as the largest sub-group, indicates that those subjects possessing the P 1 and H 1 allele have broadly similar mean ACR concentrations, while P 2 P 2 and H 2 H 2 homozygotes have significantly higher mean concentrations (Table 3 ). This suggests a recessive effect of the P 2 and H 2 alleles, rather than a gene dose effect. Consequently, subsequent analyses were done comparing subjects homozygous for these recessive alleles with those possessing the P 1 and H 1 alleles. Further support for this observation was derived from our findings whereby only a minority of patients who were homozygous for the recessive alleles had normoalbuminuria, in contrast to alternative genotypes who exhibited similar categorical distributions (Table 5) .
Urinary ACRs by genotype, excluding proteinurics, are shown in Table 3 . Individuals homozygous for the P 2 allele had a significantly elevated mean ACR (P 2 P 2 vs P 1 P 1 +P 1 P 2 , 5.0±0.5 vs 3.4±0.3, p=0.0004). Due to potential increase in genetic heterogeneity introduced by the non-Caucasian sub-group, we also explored the genotypic relationships within the Caucasian group. Our power calculations before the study gave us an 80% power of detecting a 30% difference in ACR amongst Caucasians (n=266), but the statistical power to examine the relationships in non-Caucasians (n=120) was not adequate. Caucasian P 2 homozygotes had a higher mean ACR (P 2 P 2 vs P 1 P 1 +P 1 P 2 , 5.1±0.6 vs 3.1±0.3, p=0.0003), which was observed in Caucasian men (4.4±0.7 vs 2.9±0.4, p=0.01) and women (5.8±0.9 vs 3.4±0.6, p=0.01). A similar trend was seen in the non-Caucasians. Likewise, individuals homozygous for the H 2 allele had a higher mean ACR (H 2 H 2 vs H 1 H 1 +H 1 H 2 , 4.3±0.4 vs 3.4±0.3, p=0.04), which was also observed in all subgroups. All but two of these analyses remain significant after correction for multiple analysis using Bonferroni's correction (see Table 3 ).
These comparisons were repeated after including patients whose ACR was in the proteinuric range, as shown in Table 4 . Individuals homozygous for the P 2 allele had a higher mean ACR (P 2 P 2 vs P 1 Previous data suggests that the LPL gene could be associated with hypertension [39] , which in turn is a recognised risk factor for MA [5] thus the data was analysed with respect to blood pressure. There were no differences in BP between the various genotypes (P 2 P 2 vs P 1 (Table 7) demonstrated that for the whole cohort, sex (p=0.003), diastolic BP (p=0.035), creatinine (p=0.002) and Pvu II genotype (p=0.005) were independently predictive of degree of ACR, with systolic BP showing a trend (p=0.057). Analysis of the Caucasian subgroup showed that only HbA 1 (p=0.0022), creatinine (p<0.0001) and Pvu II genotype (p<0.0001) were independently predictive of ACR. The absence of an association of Asn 291 -Ser with microalbuminuria in our study is in keeping with the previous report in Type I diabetic nephropathy [37] but our observations with the Hind III and Pvu II polymorphisms do not agree with their conclusions, though the investigators did not study these intronic markers. Our data could be explained by the higher heterozygosity of the intronic polymorphisms that we investigated, as they are more informative when investigating polygenic diseases [40, 41] . Our intronic polymorphisms had heterozygosity indices of 0.498 and 0.375, while the exonic mutations had indices of 0.02, 0.075 and 0.18. Thus it is not unexpected that our observations with the R 2 allele of the Asn 291 -Ser mutation (prevalence of 1% amongst total cohort, 2% of Caucasians) were similar to that previously reported in a similar sized cohort of Type I diabetic patients [37] . The observations with the more prevalent intronic polymorphisms might not have translated into associations with the exonic polymorphisms because the latter occur at substantially lower frequency. It is therefore unlikely that the power of our study is sufficient to explore these specific exonic mutations fully, although it was adequately powered to evaluate the relationship of the gene with microalbuminuria utilising the intronic polymorphisms.
Our data concerning mean ACR concentrations and genotypes best fits a recessive pattern of inheritance for the effects of the LPL gene upon urinary albumin excretion in our cohort. Further examination of our subjects with albumin excretion considered in three standard categories, showed that P 2 homozygotes for the recessive alleles were significantly less likely to have normoalbuminuria than those subjects with alternative genotypes, providing additional support for this mode of transmission. However, our findings are less clear when including patients with albumin excretion in the proteinuric range, as our data is skewed by a minority of individuals with markedly higher concentrations.
In view of the fact that certain of the polymorphic alleles examined were in linkage disequilibrium, the examination of haplotypes would provide a powerful tool to investigate this gene. However, given the number of polymorphic variants that we investigated and the large number of haplotypes these would generate, such analyses were beyond the scope of our study, which did not have the statistical power or design to undertake such a task.
A new candidate gene for the development and progression of microalbuminuria in Type II diabetes therefore emerges from our data and supports a direct role for lipids/lipoproteins in this disease process. Although the P 2 allele was independently associated with microalbuminuria, it is worth noting that LPL variants have previously been shown to correlate with development and severity of coronary artery disease [24, 25, 26, 33] , hence the association of P 2 with MA could, in part, be derived from the independent relationship of LPL genotypes and microalbuminuria with cardiovascular disease.
Higher concentrations of total cholesterol, LDL cholesterol, triglycerides and apo-B have all previously been correlated with either progression to micro/macroalbuminuria or deterioration in renal function in both Type 1 and Type II diabetic patients [20, 21, 42, 43] . Possible mechanisms for an effect of lipids and lipoproteins on diabetic nephropathy could include mesangial cell proliferation, recruitment of macrophages, cytokine responses and matrix deposition [15] . The association between global glomerulosclerosis and atherosclerosis has been noted previously [44] and the presence of foam cells in multiple chronic inflammatory diseases, including atherosclerosis and many glomerulopathies, suggests a common pathogenesis. Evidence suggests foam cells are derived by the de-regulated uptake of modified LDL by scavenger receptors on macrophage/monocytes and mesangial cells [45, 46] . Foam cell formation is also promoted by triglyceride-rich lipoproteins, most notably VLDL. Given, that both clearance of triglyceride-rich lipoproteins and LDL generation are influenced by lipoprotein lipase activity, this enzyme could play a key role in the mesangial cell pathology.
Hypertension is known to be a risk factor for diabetic nephropathy [5] , thus our observation that systolic BP was also an independent predictor for microalbuminuria was expected. It is now well established that lowering BP attenuates microalbuminuria in Type II diabetes, with specific agents such as angiotensin converting enzyme inhibitors and angiotensin II receptor blockers conferring superior benefit in certain patients, when compared to other agents with comparable blood pressure reductions. Therefore early targeting of patients at highest risk of developing DN could be important in the future. Identification of individuals at genetically higher risk could also be important in targeting more aggressive management of dyslipidaemia as well as other risk factors. To help clarify the relationship between LPL, lipoproteins and DN, further examination of underlying mechanisms and confirmation of our observations in larger prospective studies could be appropriate, which could proceed to interventional trials using lipid modifying pharmacotherapy.
A strength of this study is that the cohort of patients was specifically and sequentially recruited from a routine diabetic clinic and is therefore likely to reflect risk factor prevalence and clinical practice in the UK. Weaknesses include the use of spot urine samples for ACR, which we recognise is not as robust a quantitative measure of MA as a timed urine collection for calculation of albumin excretion rate (AER). However, spot ACR and AER are highly correlated [47] . The former is therefore commonly accepted for the derivation of an estimated AER, particularly as the day-today variation in AER could be as large as the imprecision of the derivation [48] . We used ACR because at the time of the earliest measurements for microalbuminuria, ACR was the routine investigation in our clinic. Association studies are also known to suffer from type 1 errors which must be borne in mind when interpreting the data.
Our observations suggest that genetic variation in the lipoprotein lipase gene could be important in the development and progression of diabetic nephropathy, and support the role of lipoprotein metabolism in this process. The relative importance of lipid and lipoprotein metabolism to other recognised risk factors merits further consideration. It could also be appropriate to evaluate our findings in the full range of diabetic renal disease, in order to identify potential mechanisms by which dyslipoproteinaemia influences renal function.
